Easywell Biomedicals (ROCO:1799) Total Liabilities : NT$629.6 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Easywell Biomedicals Total Liabilities?

Easywell Biomedicals's Total Liabilities for the quarter that ended in Mar. 2024 was NT$629.6 Mil.

Easywell Biomedicals's quarterly Total Liabilities increased from Sep. 2023 (NT$509.70 Mil) to Dec. 2023 (NT$589.99 Mil) and increased from Dec. 2023 (NT$589.99 Mil) to Mar. 2024 (NT$629.63 Mil).

Easywell Biomedicals's annual Total Liabilities increased from Dec. 2021 (NT$351.82 Mil) to Dec. 2022 (NT$402.60 Mil) and increased from Dec. 2022 (NT$402.60 Mil) to Dec. 2023 (NT$589.99 Mil).

Easywell Biomedicals Total Liabilities Historical Data

The historical data trend for Easywell Biomedicals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easywell Biomedicals Total Liabilities Chart

Easywell Biomedicals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

476.69

344.20

351.82

402.60

589.99

Easywell Biomedicals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															408.53	453.73	509.70	589.99	629.63

Easywell Biomedicals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Easywell Biomedicals's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	127.567	+	(330.448	+	131.973
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	590.0

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1213.784	-	623.796
	=	590.0

Easywell Biomedicals's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	137.358	+	(349.67	+	142.598
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	629.6

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1388.241	-	758.615
	=	629.6

Easywell Biomedicals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Easywell Biomedicals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Easywell Biomedicals (ROCO:1799) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.10, Yanfa 2nd Rd, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076

Website

http://www.easywellbio.com/en/index.php

Easywell Biomedicals Inc is engaged in the design, manufacture, and sales of thermometers for measuring body temperature and other medical instruments such as digital clinical thermometers, infrared ear thermometers, probe covers, and blood/urine/total cholesterol metabolites monitoring systems, among others. It has a Drug development segment and Other segments.

Easywell Biomedicals (ROCO:1799) Headlines

No Headlines